Bruce Jackson
Stock Analyst at Benchmark
(1.12)
# 3,823
Out of 5,090 analysts
123
Total ratings
31.25%
Success rate
-15.99%
Average return
Main Sectors:
Stocks Rated by Bruce Jackson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABT Abbott Laboratories | Initiates: Buy | $145 | $125.08 | +15.93% | 1 | Oct 10, 2025 | |
| CV CapsoVision | Initiates: Speculative Buy | $5 | $6.90 | -27.54% | 1 | Jul 28, 2025 | |
| BFRI Biofrontera | Maintains: Buy | $7 → $2.75 | $0.84 | +229.10% | 8 | May 19, 2025 | |
| HUMA Humacyte | Maintains: Buy | $17 → $14 | $1.23 | +1,038.21% | 15 | May 14, 2025 | |
| HBIO Harvard Bioscience | Maintains: Speculative Buy | $4.5 → $3 | $0.76 | +295.94% | 6 | May 13, 2025 | |
| CLNN Clene | Maintains: Buy | $84 → $33 | $5.77 | +471.92% | 8 | May 8, 2025 | |
| GNLX Genelux | Maintains: Speculative Buy | $25 → $23 | $4.64 | +395.69% | 7 | May 8, 2025 | |
| BLTE Belite Bio | Reiterates: Buy | $80 | $150.00 | -46.67% | 9 | Mar 26, 2025 | |
| NEO NeoGenomics | Reiterates: Hold | n/a | $11.90 | - | 8 | Jan 16, 2025 | |
| EXAS Exact Sciences | Reiterates: Buy | $65 | $101.06 | -35.68% | 7 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $0.30 | - | 3 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $30 | $6.23 | +381.54% | 8 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $1.25 | $0.35 | +253.11% | 2 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $3 | $1.21 | +148.96% | 3 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $1.77 | +182.49% | 4 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $300 | $8.85 | +3,289.83% | 2 | Sep 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $60 | $3.65 | +1,543.84% | 5 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $17 | $0.62 | +2,659.29% | 4 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $24 | $1.12 | +2,042.86% | 3 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $0.46 | +995.53% | 4 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.46 | - | 7 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $25.38 | - | 7 | Sep 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Speculative Buy | $800 | $2.67 | +29,862.55% | 1 | Aug 8, 2022 |
Abbott Laboratories
Oct 10, 2025
Initiates: Buy
Price Target: $145
Current: $125.08
Upside: +15.93%
CapsoVision
Jul 28, 2025
Initiates: Speculative Buy
Price Target: $5
Current: $6.90
Upside: -27.54%
Biofrontera
May 19, 2025
Maintains: Buy
Price Target: $7 → $2.75
Current: $0.84
Upside: +229.10%
Humacyte
May 14, 2025
Maintains: Buy
Price Target: $17 → $14
Current: $1.23
Upside: +1,038.21%
Harvard Bioscience
May 13, 2025
Maintains: Speculative Buy
Price Target: $4.5 → $3
Current: $0.76
Upside: +295.94%
Clene
May 8, 2025
Maintains: Buy
Price Target: $84 → $33
Current: $5.77
Upside: +471.92%
Genelux
May 8, 2025
Maintains: Speculative Buy
Price Target: $25 → $23
Current: $4.64
Upside: +395.69%
Belite Bio
Mar 26, 2025
Reiterates: Buy
Price Target: $80
Current: $150.00
Upside: -46.67%
NeoGenomics
Jan 16, 2025
Reiterates: Hold
Price Target: n/a
Current: $11.90
Upside: -
Exact Sciences
Jan 13, 2025
Reiterates: Buy
Price Target: $65
Current: $101.06
Upside: -35.68%
Nov 22, 2024
Reiterates: Hold
Price Target: n/a
Current: $0.30
Upside: -
Nov 22, 2024
Reiterates: Speculative Buy
Price Target: $30
Current: $6.23
Upside: +381.54%
Nov 20, 2024
Reiterates: Speculative Buy
Price Target: $1.25
Current: $0.35
Upside: +253.11%
Oct 11, 2024
Reiterates: Speculative Buy
Price Target: $3
Current: $1.21
Upside: +148.96%
Oct 10, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $1.77
Upside: +182.49%
Sep 4, 2024
Reiterates: Speculative Buy
Price Target: $300
Current: $8.85
Upside: +3,289.83%
Aug 27, 2024
Reiterates: Speculative Buy
Price Target: $60
Current: $3.65
Upside: +1,543.84%
Aug 26, 2024
Reiterates: Speculative Buy
Price Target: $17
Current: $0.62
Upside: +2,659.29%
Aug 14, 2024
Reiterates: Speculative Buy
Price Target: $24
Current: $1.12
Upside: +2,042.86%
Mar 21, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $0.46
Upside: +995.53%
Nov 14, 2023
Downgrades: Hold
Price Target: n/a
Current: $1.46
Upside: -
Sep 15, 2023
Downgrades: Hold
Price Target: n/a
Current: $25.38
Upside: -
Aug 8, 2022
Initiates: Speculative Buy
Price Target: $800
Current: $2.67
Upside: +29,862.55%